TABLE 3.

Levels of CT, 3α,7α,12α-trihydroxycoprostane, and 7-KC before and after chenodeoxy-cholic treatment in CTX patients

	CT		3α,7α,12α-Trihydroxycoprostane		7-KC
CTX Patient	Pre-T	Post-T	Pre-T	Post-T	Pre-T	Post-T
CTX-1	28	35	1,251	24	596	38
CTX-2	57	88	1,732	363	838	112
CTX-3	57	47	3,101	29	1,021	51
CTX-4	55	48	2,588	121	1,529	56

T, treatment. Values are expressed as ng/ml.